RxDoctor Payments DataLook up a doctor →

Mariah White, PA

Physician Assistant · Saint Peters, MONPI 1659731529

Payments from drug & device makers

$9,668in general payments, 2019–2025

Across 603 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$871
  • Lilly USA, LLC$666
  • Pfizer$644
  • UCB, Inc.$582
  • Teva Pharmaceuticals USA, Inc.$488
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$9,28496%
  • Education$3844%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,668 in reported general payments places this provider in the 95th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Medicare billing

Part B allowed, 2024
$29,642
Medicare patients
139
Services billed
1,199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BriviactBrivaracetam25$46,846
UbrelvyUbrogepant11$10,507
Carbamazepine ErCarbamazepine17$4,511
Divalproex Sodium30$1,724
Topiramate37$1,547
Gabapentin49$1,180
Pregabalin36$1,112
Primidone49$1,098
Memantine Hcl32$1,070
Carbidopa-LevodopaCarbidopa/Levodopa38$958
Levetiracetam35$910
Oxcarbazepine18$691
Zonisamide29$620
Nortriptyline Hcl39$590
Lamotrigine13$478

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
UCB, Inc.Briviact$582$46,84625 claims
AbbVieUbrelvy$2,414$10,50711 claims
Upsher-smith Laboratories LLCTopiramate$24$1,54737 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Saint Peters

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →